| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/14/2005 | US20050080104 Preparing 3-[(4S)-5-oxo-2-(trifluoromethyl)-1,4,5,6,7,8-hexahydroquinolin-4-yl]benzonitrile by reacting an ester of 4,4,4-trifluoro-3-oxobutanoate with 1,3-cyclohexanedione and 3-cyanobenzaldehyde, , dehydrating and de-esterifying the intermeidate |
| 04/14/2005 | US20050080097 5-[1-(hydroxymethyl)propyl]amino-7-benzylamino-3-isopropyl(methyl, ethyl)pyrazolo[4,3-d]pyrimidine for inhibiting cell proliferation, cancer, or psoriasis, rheumatoid arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, graft rejection, and neurodegerative diseases |
| 04/14/2005 | US20050080096 Condensed heterocyclic compounds |
| 04/14/2005 | US20050080081 Substituted oxazolidinones and their use in the field of blood coagulation |
| 04/14/2005 | US20050080073 Sulfonylaminocarboxiylic acid N-arylamides as guanylate cyclase activators |
| 04/14/2005 | US20050080071 Treatment methods |
| 04/14/2005 | US20050080067 Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 04/14/2005 | US20050080064 Steroids as agonists for fxr |
| 04/14/2005 | US20050080057 reducing weight in mammals; Substituted with a thio, sulfoxy or sulfonyl group eg 5-Chloro-2-methylsulfonylindan-1-ol, 5-Chloro-2-(propane-2-sulfonyl)indan-1-ol, 5-Chloro-2-ethanesulfonylindan-1-ol |
| 04/14/2005 | US20050080051 for the treatment of hyperlipidemia and blood coagulation disorders; phosphatidylinositol, phosphatidylserine, phosphatidylglycerol, or phosphatidic acid; dyslipidemia and atherosclerosis |
| 04/14/2005 | US20050080046 In liquid solvent; parenterally administering; aldosterone receptors blockers; congestive heart failure, hypotensive agents, liver disorders |
| 04/14/2005 | US20050080042 synthetic monosaccharides, disaccharides, trisaccharides, tetrasaccharides and pentasaccharides for use in the preparation of synthetic heparinoids; Vascular thrombosis, cardiovascular disease |
| 04/14/2005 | US20050080029 Administering to the cell the compound to be delivered, an organic halide, and/or a carrier; ultrasound may also be applied |
| 04/14/2005 | US20050080026 Nucleic acid molecule of MAP kinase interacting kinase gene family or polypeptide encoded thereby or fragment or variant of nucleic acid molecule, polypeptide or antibody, aptamer or receptor recognizing a nucleic acid molecule of gene family or polypeptide encoded thereby; treating metabolic diseases |
| 04/14/2005 | US20050080024 Can safely and effectively lower blood cholesterol while simultaneously decreasing endothelial dysfunction and decreasing vascular oxidative stress |
| 04/14/2005 | US20050080016 Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 04/14/2005 | US20050080013 a 15 to 22-residue polypeptide analog that forms an amphipathic alpha helix in the presence of lipids; multimeric Apo-A-1agonist; anticholesterol agents; hypercholesterolemia, septic shock |
| 04/14/2005 | US20050080008 Administering bactericidal permeability increasing protein products; anticoagulants; without severe adverse side effects |
| 04/14/2005 | US20050079581 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
| 04/14/2005 | US20050079538 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; anticarcinogenic agents |
| 04/14/2005 | US20050079537 Expression vector comprising nucleotide sequences coding membrane protein for in identifying modulator for prevention and treatment of cell proliferative, nervous system and inflammatory disorders |
| 04/14/2005 | US20050079216 Tablets, pellets in active matrix copolymer; melting, injection molding, extrusion, granulation |
| 04/14/2005 | US20050079176 Treating stress response with chemokine receptor ccr5 modulators |
| 04/14/2005 | US20050079148 Biocompatible polymer designed to release nitric oxide; extensively cross-linked polyamine-derivatized divinylbenzene; sustained release, potentiation |
| 04/14/2005 | DE10343098A1 Tetrahydrochinoxaline und ihre Verwendung Tetrahydroquinoxalines and their use |
| 04/14/2005 | DE10342108A1 Basisch-substituierte Benzylaminanaloga als Inhibitoren des Gerinnungsfaktors Xa, ihre Herstellung und Verwendung Basic-substituted Benzylaminanaloga as inhibitors of coagulation factor Xa, their preparation and use |
| 04/14/2005 | CA2545479A1 Compounds comprising a nitric oxide moiety for inducing expression of apoa1 for the treatment of cardiovascular disorders |
| 04/14/2005 | CA2541533A1 New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1 |
| 04/14/2005 | CA2540666A1 Glucocerebroside treatment of disease |
| 04/14/2005 | CA2540062A1 Novel association consisting of an anti-atherothrombotic agent and of a platelet antiaggregating agent |
| 04/13/2005 | EP1522540A1 Azaarene derivatives |
| 04/13/2005 | EP1522314A1 Remedies for diseases caused by vascular contraction or dilation |
| 04/13/2005 | EP1522310A1 Therapeutic uses of dunaliella powder |
| 04/13/2005 | EP1521824A2 Nucleic acid-associated proteins |
| 04/13/2005 | EP1521822A2 Protein modification and maintenance molecules |
| 04/13/2005 | EP1521764A2 New compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| 04/13/2005 | EP1521763A2 Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 04/13/2005 | EP1521744A1 Arylsulphonamide derivatives and use thereof as b1 bradykinin receptor antagonists |
| 04/13/2005 | EP1521742A1 Diphenylazetidinone derivatives for treating disorders of the lipid metabolism |
| 04/13/2005 | EP1521740A2 Probucol derivatives |
| 04/13/2005 | EP1521735A2 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 04/13/2005 | EP1521598A1 Adjuvant containing xenon |
| 04/13/2005 | EP1521597A1 LIQUID FORMULATIONS WITH HIGH CONCENTRATION OF HUMAN GROWTH HORMONE (hgh) COMPRISING 1,2-PROLPYLENE GLYCOL |
| 04/13/2005 | EP1521596A1 Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine |
| 04/13/2005 | EP1521590A1 Novel medicament combinations based on magnesium salts and fibrinolytics |
| 04/13/2005 | EP1521588A2 Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 04/13/2005 | EP1521584A1 Purine derivatives as liver x receptor agonists |
| 04/13/2005 | EP1521583A1 7,8,9,10-tetrahydro-6h-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2h-pyrrolo (2,1-b)-quinazolinone derivatives |
| 04/13/2005 | EP1521579A1 Novel medicament combinations based on sodium channel blockers and magnesium salts |
| 04/13/2005 | EP1480736A4 Microcapsules having high carotenoid content |
| 04/13/2005 | EP1458702B1 Luminacin analogs and uses thereof |
| 04/13/2005 | EP1366050B1 Condensed pyrazindione derivatives as pde inhibitors |
| 04/13/2005 | EP1289955B1 Piperidines for use as orexin receptor antagonists |
| 04/13/2005 | EP1268498B1 Cardioprotective phosphonates |
| 04/13/2005 | EP1212052B1 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate |
| 04/13/2005 | EP1183353B1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 04/13/2005 | EP1090105B1 Non-embryonic ependymal neural stem cells and method for their isolation |
| 04/13/2005 | EP0728210B1 Thrombin mutants |
| 04/13/2005 | CN1606566A Integrin targeting compounds |
| 04/13/2005 | CN1606563A Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 04/13/2005 | CN1606560A Novel benzothiazine and benzothiadiazine derivatives, method for preparing same, their use and pharmaceutical compositions containing same |
| 04/13/2005 | CN1606557A Deuterated pyrazolopyrimidinones and drugs containing said compounds |
| 04/13/2005 | CN1606556A Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 04/13/2005 | CN1606555A Imidazoquinoline derivatives |
| 04/13/2005 | CN1606554A Beta-lactamyl vasopressin v1aantagonists |
| 04/13/2005 | CN1606550A Benzothia(dia)zine derivatives and their use as AMPA modulators |
| 04/13/2005 | CN1606545A Pyrrolidine and piperidine derivates as nk1 antagonists |
| 04/13/2005 | CN1606457A Methods for sterilizing preparations containing albumin |
| 04/13/2005 | CN1606444A Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 04/13/2005 | CN1606440A Substituted imidazolidines, process for their preparation, and their use as a medicament or diagnostic, and medicament comprising them |
| 04/13/2005 | CN1606436A Compounds and methods of treating transplant rejection |
| 04/13/2005 | CN1606432A Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
| 04/13/2005 | CN1605347A Preparation and application of red rice dispersible tablet |
| 04/13/2005 | CN1605342A Breviscapine injection for perfusion and its preparing process |
| 04/13/2005 | CN1605341A Compound formulation for treating hypertension |
| 04/13/2005 | CN1605340A Compound formulation for treating hypertension |
| 04/13/2005 | CN1605338A Compound formulation for treating hypertension |
| 04/13/2005 | CN1605336A Application of L-butylphthalide in the process for preparing cerebral infarction preventing and treating medicine |
| 04/13/2005 | CN1196784C Promoter of human endoglin gene and its use |
| 04/13/2005 | CN1196709C Troxerutin with high trihydroxy-ethyl-rutin content and method for preparing same |
| 04/13/2005 | CN1196708C Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl)-1h-indol-5-ols |
| 04/13/2005 | CN1196687C Inhibitors of IMPDH enzyme |
| 04/13/2005 | CN1196685C Pyrimidine derivatives |
| 04/13/2005 | CN1196678C Prostaglandin E1 derivatives |
| 04/13/2005 | CN1196481C Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 04/13/2005 | CN1196479C Use of benzidine prostaglandins of inhalation form |
| 04/12/2005 | US6878826 Perfluoronated cycle-containing tertiary amines used as a basis for gas-conveying emulsions and device for the production thereof |
| 04/12/2005 | US6878817 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 04/12/2005 | US6878740 Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine compounds |
| 04/12/2005 | US6878729 Antihypoxic agents |
| 04/12/2005 | US6878726 For therapy and prophylaxis inflammation, other inflammation associated disorders, such as arthritis, neurodegeneration and colon cancer, in mammals, dogs, cats or livestock animals |
| 04/12/2005 | US6878725 Serine protease inhibitors |
| 04/12/2005 | US6878724 Polyarylcarboxamides useful as lipid lowering agents |
| 04/12/2005 | US6878718 Able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 04/12/2005 | US6878714 Prophylaxis and treatment of angiogenesis mediated diseases such as cancer |
| 04/12/2005 | US6878712 E.g., (R)-((2S,5R)-2-methyl-5-methyl-4-(4-carboxyphenyl-sulphonyl)-1-(3,3,3 -trifluoro-2-hydroxy-2-methylpropionyl)-piperazine); antidiabetic agents |
| 04/12/2005 | US6878711 Indole derivatives as PDE5-inhibitors |
| 04/12/2005 | US6878709 Treating acute and chronic inflammatory disorders and cancer. |
| 04/12/2005 | US6878708 Imidazotriazinones and the use thereof |
| 04/12/2005 | US6878707 Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion |